Elevance Health Statistics

Total Valuation

Elevance Health has a market cap or net worth of GBP 67.51 billion. The enterprise value is 82.93 billion.

Market Cap	67.51B
Enterprise Value	82.93B

Important Dates

The next estimated earnings date is Wednesday, January 22, 2025.

Earnings Date	Jan 22, 2025
Ex-Dividend Date	Dec 5, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.98%
Shares Change (QoQ)	-0.13%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	231.38M

Valuation Ratios

The trailing PE ratio is 14.10.

PE Ratio	14.10
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	12.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.19, with an EV/FCF ratio of 127.61.

EV / Earnings	17.32
EV / Sales	0.60
EV / EBITDA	9.19
EV / EBIT	9.82
EV / FCF	127.61

Financial Position

The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.62.

Current Ratio	1.50
Quick Ratio	1.34
Debt / Equity	0.62
Debt / EBITDA	2.39
Debt / FCF	31.17
Interest Coverage	9.61

Financial Efficiency

Return on equity (ROE) is 15.50% and return on invested capital (ROIC) is 9.81%.

Return on Equity (ROE)	15.50%
Return on Assets (ROA)	5.84%
Return on Capital (ROIC)	9.81%
Revenue Per Employee	1.24M
Profits Per Employee	45,648
Employee Count	104,900
Asset Turnover	1.53
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.22%
50-Day Moving Average	409.95
200-Day Moving Average	498.14
Relative Strength Index (RSI)	29.38
Average Volume (20 Days)	18,843

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.45

Income Statement

In the last 12 months, Elevance Health had revenue of GBP 129.83 billion and earned 4.79 billion in profits. Earnings per share was 20.45.

Revenue	129.83B
Gross Profit	36.27B
Operating Income	7.92B
Pretax Income	6.19B
Net Income	4.79B
EBITDA	8.47B
EBIT	7.92B
Earnings Per Share (EPS)	20.45

Full Income Statement

Balance Sheet

The company has 28.30 billion in cash and 20.26 billion in debt, giving a net cash position of -14.39 billion.

Cash & Cash Equivalents	28.30B
Total Debt	20.26B
Net Cash	-14.39B
Net Cash Per Share	n/a
Equity (Book Value)	32.74B
Book Value Per Share	140.82
Working Capital	15.53B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.59 billion and capital expenditures -940.09 million, giving a free cash flow of 649.85 million.

Operating Cash Flow	1.59B
Capital Expenditures	-940.09M
Free Cash Flow	649.85M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 27.94%, with operating and profit margins of 6.10% and 3.69%.

Gross Margin	27.94%
Operating Margin	6.10%
Pretax Margin	4.77%
Profit Margin	3.69%
EBITDA Margin	6.52%
EBIT Margin	6.10%
FCF Margin	0.50%

Dividends & Yields

This stock pays an annual dividend of 5.08, which amounts to a dividend yield of 1.38%.

Dividend Per Share	5.08
Dividend Yield	1.38%
Dividend Growth (YoY)	6.22%
Years of Dividend Growth	6
Payout Ratio	23.08%
Buyback Yield	1.98%
Shareholder Yield	1.98%
Earnings Yield	6.96%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a